Nano‐in‐Micro Sildenafil Dry Powder Formulations for the Treatment of Pulmonary Arterial Hypertension Disorders: The Synergic Effect of POxylated Polyurea Dendrimers, PLGA, and Cholesterol.

MLA

Restani, Rita B., et al. “Nano‐in‐Micro Sildenafil Dry Powder Formulations for the Treatment of Pulmonary Arterial Hypertension Disorders: The Synergic Effect of POxylated Polyurea Dendrimers, PLGA, and Cholesterol.” Particle & Particle Systems Characterization, vol. 37, no. 6, June 2020, pp. 1–9. EBSCOhost, https://doi.org/10.1002/ppsc.201900447.

APA

Restani, R. B., Pires, R. F., Baptista, P. V., Fernandes, A. R., Casimiro, T., Bonifácio, V. D. B., & Aguiar, R. A. (2020). Nano‐in‐Micro Sildenafil Dry Powder Formulations for the Treatment of Pulmonary Arterial Hypertension Disorders: The Synergic Effect of POxylated Polyurea Dendrimers, PLGA, and Cholesterol. Particle & Particle Systems Characterization, 37(6), 1–9. https://doi.org/10.1002/ppsc.201900447

Chicago

Restani, Rita B., Rita F. Pires, Pedro V. Baptista, Alexandra R. Fernandes, Teresa Casimiro, Vasco D. B. Bonifácio, and Ricardo, Ana Aguiar. 2020. “Nano‐in‐Micro Sildenafil Dry Powder Formulations for the Treatment of Pulmonary Arterial Hypertension Disorders: The Synergic Effect of POxylated Polyurea Dendrimers, PLGA, and Cholesterol.” Particle & Particle Systems Characterization 37 (6): 1–9. doi:10.1002/ppsc.201900447.